Essential Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Essential Partners's ATEX Position: Q2 2026 in Review
Essential Partners reduced its Anterix (ATEX) stake by 5.9% in Q2 2026, selling an estimated $59 and leaving 16 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2054.
Essential Partners first reported a position in ATEX in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Essential Partners held 16 shares of Anterix worth $1.65K as of Q2 2026.
- Essential Partners sold 1 Anterix share in Q2 2026, an estimated $59.
- Anterix made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2054 holding.
- Essential Partners first reported a position in Anterix in Q2 2025 and has held it in 5 quarters since.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.